Jump to content

Jeannie Callum

From Wikipedia, the free encyclopedia
A photograph of Dr. Jeannie Callum with hands clasped, facing the camera
Jeannie Callum

Jeannie Callum is a transfusion medicine specialist and hematologist in Ontario, Canada.[1] She is also a professor at the University of Toronto and Queen's University.[2] She was the co-principal investigator of the CONCOR[3] trial, an international randomized controlled trial evaluating the use of convalescent plasma for the treatment of COVID-19 infection.[2][4] She was lead editor for Bloody Easy 4: Blood Transfusions, Blood Alternatives and Transfusion Reactions, fourth edition a handbook in transfusion medicine for the province of Ontario.[5]

Career and Research

[edit]

Jeannie L. Callum, MD, FRCPC, is a Canadian transfusion medicine specialist and hematologist based in Ontario, where she serves as Professor in the Departments of Pathology & Molecular Medicine at Queen’s University and Laboratory Medicine & Pathobiology at the University of Toronto. As Director of Transfusion Medicine at Kingston Health Sciences Centre and an associate scientist at Sunnybrook Research Institute, she has focused on improving blood utilization, tracking transfusion-related errors, and managing coagulopathy in trauma and post-cardiac surgery patients. Callum was co-principal investigator on the CONCOR‑1 trial evaluating convalescent plasma for COVID‑19, lead author of Bloody Easy (the Ontario provincial transfusion handbook), and an author or editor of over 150 peer-reviewed publications.[6][7]

Further reading

[edit]
  • "Bloody Easy 4: Blood Transfusions, Blood Alternatives and Transfusion Reactions. A Guide to Transfusion Medicine, fourth Edition Handbook". Ontario Regional Blood Coordinating Network. Retrieved 2021-11-09.
  • "Bloody Easy 4: Blood Transfusions, Blood Alternatives and Transfusion Reactions" (PDF). 2016. Retrieved November 9, 2021.

References

[edit]
  1. ^ "Using plasma to treat COVID-19 still in question after clinical trial results". CBC. Retrieved November 9, 2021.
  2. ^ a b "Major study finds convalescent plasma doesn't help seriously ill COVID-19 patients". Newswise. September 9, 2021. Retrieved November 9, 2021.
  3. ^ Bégin, Philippe; Callum, Jeannie; Jamula, Erin; Cook, Richard; Heddle, Nancy M.; Tinmouth, Alan; Zeller, Michelle P.; Beaudoin-Bussières, Guillaume; Amorim, Luiz; Bazin, Renée; Loftsgard, Kent Cadogan (2021-09-09). "Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial". Nature Medicine. 27 (11): 2012–2024. doi:10.1038/s41591-021-01488-2. ISSN 1546-170X. PMC 8604729. PMID 34504336. S2CID 237469785.
  4. ^ "Large Study Finds Convalescent Plasma Doesn't Help Seriously Ill COVID-19 Patients". WCM Newsroom. Retrieved 2021-11-09.
  5. ^ Bain, B. J. (2005-06-01). "Bloody Easy: Blood Transfusions, Blood Alternatives and Transfusion Reactions: a Guide to Transfusion Medicine". Journal of Clinical Pathology. 58 (6): 672. ISSN 0021-9746.
  6. ^ https://pathology.queensu.ca/faculty-staff/jeannie-callum
  7. ^ https://research.sunnybrook.ca/researchers/jeannie-callum/


Stub icon

This hematology article is a stub. You can help Wikipedia by expanding it.

Flag of CanadaBiography icon

This biography related to medicine in Canada is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Jeannie_Callum&oldid=1295118558"